The SUO-CTC participates in a variety of clinical trials across patient populations with urologic cancers; primarily trials are conducted in patients with bladder cancer, prostate cancer and renal cell carcinoma.
The SUO-CTC is predominantly a U.S. organization with 198 sites in the U.S. and additional sites in Canada. These sites represent in excess of 425 individual members dedicated to the successful conduct of clinical trials for their patients with urologic cancers.
Publication of results is an integral part of the research process and an important activity within the larger medical community. To that end SUO-CTC investigators work to advance scientific information and discovery through abstracts, presentations, and publications of protocol finding where they have contributed research data.